Search PDMR transactions

Notifier
Name of person with notification obligation
Fredrik Järrsten Konsult AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Fredrik Järrsten
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oasmia Pharmaceutical AB
Issuer´s LEI code
5493003TZPR4B7QO9L49
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oasmia Pharmaceutical AB SE0000722365 Acquisition 20,000 Quantity 2.91 SEK 14/07/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oasmia Pharmaceutical AB SE0000722365 Acquisition 14/07/2021 NASDAQ STOCKHOLM AB 20,000 (Quantity) 2.91 SEK
Total: 20,000
<< Back